ClinicalTrials.Veeva

Menu

A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

N

National University Health System (NUHS)

Status

Unknown

Conditions

NSCLC

Treatments

Other: EGFR mutation status in patients

Study type

Observational

Funder types

Other

Identifiers

NCT01100827
NS01/03/10

Details and patient eligibility

About

To determine EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC.

To determine the association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

Nil

Exclusion criteria

Nil

Trial design

0 participants in 1 patient group

EGFR mutation status in patients
Treatment:
Other: EGFR mutation status in patients

Trial contacts and locations

1

Loading...

Central trial contact

Ross Andrew Soo, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems